Buerkley Rose, MSN, RN, discusses how the University of Chicago’s mesothelioma program has adapted during the COVID-19 pandemic:
- Clinical Trials: Paused.
- Telemedicine, including psycho-oncology services: Available.
- Surgery: Paused.
Buerkley is a nurse navigator and a member of the Foundation’s Board of Directors.
Watch MesoTV
This MesoTV interview was made possible by the support of sponsors who have stepped up during this difficult time to ensure that we can continue serving the mesothelioma community. Please take note of them at the beginning of the video: Novocure; Belluck & Fox, LLP; University of Pittsburgh Medical Center (UPMC); Vogelzang Law; and Merrill Lynch.
Get notified when our next video is published by clicking the red “Subscribe” button below.
MesoTV is the Mesothelioma Applied Research Foundation’s recorded video series covering pertinent conversations impacting the mesothelioma community. You can learn more at curemeso.org/mesotv.
